Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service sleep apnea & airway implants cases in Iowa: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 15% on average (12 state-years, 2020–2024): small markets swing, so treat it as rough.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2021 | 2 | 46 | 27% |
| 2022 | 4 | 112 | 34% |
| 2023 | 6 | 144 | 38% |
| 2024 | 6 | 171 | 40% |
| 2025 from claims | – | 87 70–102 | 41% |
| 2026 forecast | – | 97 76–122 | 40% |
| 2027 forecast | – | 106 78–140 | 40% |
| 2028 forecast | – | 115 82–159 | 41% |
| 2029 forecast | – | 126 86–181 | 41% |
| 2030 forecast | – | 138 90–204 | 42% |
Hypoglossal nerve stimulation and upper airway procedures. Professional codes (what the surgeon bills): CPT 64582, 64583, 64584, 42145, 41530.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in Iowa; 4 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 64% hospital outpatient, 36% surgery center. The share outside the hospital has moved −4 pts since 2022.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Ohio | 7 | 262+60%/yr | +60%/yr | 0.2 | 0% | 230 in 2030−2.4%/yr |
| Missouri | 11 | 224+173%/yr | +173%/yr | 0.3 | 0% | 150 in 2030−6.1%/yr |
| Illinois | 5 | 187+137%/yr | +137%/yr | 0.1 | 0% | 160 in 2030−2.3%/yr |
| Indiana | 3 | 142+50%/yr | +50%/yr | 0.2 | 9% | 190 in 2030+4.8%/yr |
| Kansas | 5 | 135+70%/yr | +70%/yr | 0.3 | 0% | 140 in 2030+0.8%/yr |
| Nebraska | 2 | 105+149%/yr | +149%/yr | 0.4 | 19% | 90 in 2030−2.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 11 | 1,050−4.1%/yr | −4.1%/yr | 2.40.7× | 89% | 1,110 in 2030+1%/yr |
| Ear tubes & middle ear surgery | 1 | 146−9.8%/yr | −9.8%/yr | 0.31.0× | 47% | 110 in 2030−5%/yr |
Sleep apnea & airway implants in every state, and its device makers · Every procedure market in Iowa · Every state · Compare with Ohio
Inspire Medical Systems leads with 96% of company spending on these surgeons in 2025, +15 pts on 2024.
In 2025, 7 companies reported engagement with Iowa’s surgeons worth $124K in consulting, speaking, meals and travel tied to these products, about $21K per surgeon billing it. Royalties are left out.
FDA, last 12 months: 18 clearances and approvals in the category, 2 recalled product lines. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.